Bolt Biotherapeutics, Inc.
BOLT
$3.68
-$0.18-4.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.60M | 22.89M | 27.51M | 31.91M | 34.77M |
| Total Receivables | 13.00K | 15.00K | 973.00K | 948.00K | 100.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.75M | 2.65M | 1.41M | 1.96M | 2.68M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 200.00K | 200.00K | 375.00K | 784.00K | 784.00K |
| Total Current Assets | 20.56M | 25.75M | 30.26M | 35.61M | 38.34M |
|
|
|||||
| Total Current Assets | 20.56M | 25.75M | 30.26M | 35.61M | 38.34M |
| Net Property, Plant & Equipment | 17.65M | 19.61M | 20.48M | 21.38M | 22.24M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.63M | 1.65M | 1.68M | 1.16M | 1.20M |
| Total Assets | 40.34M | 48.03M | 56.75M | 65.05M | 75.50M |
|
|
|||||
| Total Accounts Payable | 868.00K | 1.74M | 1.44M | 1.52M | 1.85M |
| Total Accrued Expenses | 3.06M | 1.76M | 2.97M | 3.84M | 5.35M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.09M | 2.96M | 2.83M | 2.70M | 2.56M |
| Total Finance Division Other Current Liabilities | 847.00K | 896.00K | 1.19M | 1.91M | 2.55M |
| Total Other Current Liabilities | 847.00K | 896.00K | 1.19M | 1.91M | 2.55M |
| Total Current Liabilities | 7.87M | 7.34M | 8.44M | 9.97M | 12.31M |
|
|
|||||
| Total Current Liabilities | 7.87M | 7.34M | 8.44M | 9.97M | 12.31M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 18.53M | 19.35M | 20.13M | 20.89M | 21.62M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.30M | 1.51M | 1.68M | 2.10M | 2.72M |
| Total Liabilities | 27.70M | 28.21M | 30.24M | 32.95M | 36.66M |
|
|
|||||
| Common Stock & APIC | 488.43M | 487.86M | 487.31M | 486.26M | 485.85M |
| Retained Earnings | -475.74M | -468.02M | -460.78M | -454.15M | -447.00M |
| Treasury Stock & Other | -44.00K | -11.00K | -21.00K | -10.00K | -6.00K |
| Total Common Equity | 12.64M | 19.82M | 26.51M | 32.10M | 38.84M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.64M | 19.82M | 26.51M | 32.10M | 38.84M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.64M | 19.82M | 26.51M | 32.10M | 38.84M |
|
|
|||||